Stroke: Vascular and Interventional Neurology (Mar 2023)

Abstract Number: LBA14 Incidence of Intracranial Hemorrhage & Clinical Outcomes in Fast Versus Slow Progressors as per ASPECTS

  • Farah Fourcand,
  • Sindhu Sahito,
  • Farah Fourcand,
  • Arifa Ghori,
  • Hamidreza Abbasi,
  • Zamir Singh,
  • Rudra Joshi,
  • Abdallah Amireh,
  • Nancy Gadallah,
  • Navid Tabibzadeh,
  • Siddhart Mehta,
  • Jawad Kirmani

DOI
https://doi.org/10.1161/SVIN.03.suppl_1.LBA14
Journal volume & issue
Vol. 3, no. S1

Abstract

Read online

Introduction Heterogeneity of collateralization in patients with acute ischemic stroke (AIS) is a marker of fast versus slow progression of penumbral consumption and infarct expansion. Our aim was to evaluate the relationship between time‐dependent stroke progression and incidence of intracranial hemorrhage (ICH) and acute neurological deficits. Methods Retrospective chart review of patients presenting with anterior circulation large vessel occlusion (LVO)‐associated AIS at our comprehensive stroke center with 24 hours last known normal (LKN) who underwent endovascular thrombectomy (EVT) without intra‐arterial thrombolytics or non‐thrombolytics were included. We used Alberta Stroke Program Early CT Score (ASPECTS) on initial non‐contrast CT to identify slow versus fast progressors. ASPECTS 7 and < = 7 (Fisher value = 0.018). Sample size was not large enough to perform subgroup analysis based on last known normal. However, there was a trend towards increase in hemorrhagic transformation rate with greater time from last known well at same ASPECTS score. Slow progressors also had a significant improvement in presenting and discharge NIHSS as compared to fast progressors (z‐score is ‐3.10, p‐value is 0.002). Conclusions Our study suggests that ASPECTS score as assessed in different time windows to differentiate fast versus slow progressors is not only a predictor of clinical outcome, but also independently associated with risk of hemorrhagic transformation. Larger, prospective studies are needed to validate our results.